SMP-105

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSMP-105
Drug Alias NameTLR-2 agonist (DSP)SMP-105
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 2 agonists
TargetsToll like receptor 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSumitomo Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSumitomo Pharmaceuticals Co Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A